Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC).
暂无分享,去创建一个
M. Tsao | F. Shepherd | S. Kamel‐Reid | Geoffrey Liu | C. Mascaux | M. Pintilie | P. Tomasini | N. Leighl | R. Feld | M. Cabanero | M. Doherty | P. Bradbury | C. Labbé | K. Jao | G. Korpanty | B. Pitcher | Rick Wang